Source: International Congress 2017 – The wide spectrum of ILDs
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Garcia Moyano (Barakaldo, Spain). Post-transplant morbidity and mortality in patients with pulmonary fibrosis and telomeric shortening. 2954

Member's Comments

No comment yet.

Related content which might interest you: Surgical morbidity and mortality in lung cancer patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 782s Year: 2006 Respiratory comorbidities and risk of mortality in hospitalized patients with idiopathic pulmonary fibrosis. Source: International Congress 2017 – ILDs: clinical aspects Year: 2017 Morbidity and mortality in patients with chronic obstructive pulmonary disease and cachexia Source: Annual Congress 2009 - Prognosis and comorbidities in COPD Year: 2009 Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease Source: Eur Respir J 2011; 39: 125-132 Year: 2012 Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease Source: Eur Respir J 2012; 39: 125-132 Year: 2012 Pulmonary and extrapulmonary morbidity and mortality in COPD Source: School Course 2012 - Clinical challenges in COPD: a bedside teaching course Year: 2012 Effect of delayed secondary care referral on morbidity and mortality in idiopathic pulmonary fibrosis patients treated with antifibrotics Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis Year: 2019 The impact of dynamic lung hyperinflation on morbidity and mortality in patients with chronic obstructive pulmonary disease Source: Annual Congress 2009 - Risk factors for COPD Year: 2009 Hospital readmission rate and mortality after severe exacerbation of chronic obstructive pulmonary disease Source: International Congress 2017 – Latest insights into the management of chronic lung diseases Year: 2017 Increase in post-transplant survival and quality of life in pulmonary fibrosis with and without telomere dysfunction Source: Virtual Congress 2020 – Possible scenarios in the challenging future of rare diffuse parenchymal lung diseases Year: 2020 Factors affecting mortality and morbidity in patients with bronchiectasis Source: Annual Congress 2010 - Lung morbidity on exposure to various agents Year: 2010 Cardiovascular comorbidity and mortality in patients with chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD epidemiology Year: 2012 Hospital readmission increases short and long – term mortality in patients with interstitial lung disease after acute respiratory worsening. Source: International Congress 2017 – The wide spectrum of ILDs Year: 2017 Cardiovascular mortality and morbidity in pulmonary embolism Source: Eur Respir Monogr 2020; 88: 184-197 Year: 2020 Pulmonary vascular disease(PC) and risk of mortality in patients with idiopathic pulmonary fibrosis(IPF) Source: International Congress 2018 – Pulmonary embolism: long-term sequelae and advances in therapies Year: 2018 Pulmonary vascular resistance predicts mortality in patients with pulmonary hypertension associated with interstitial lung disease: results from the COMPERA registry Source: Eur Respir J, 58 (2) 2101483; 10.1183/13993003.01483-2021 Year: 2021 Diffuse alveolar haemorrhage: factors associated with in-hospital and long-term mortality Source: Eur Respir J 2010; 35: 1303-1311 Year: 2010 Predictors of death or transplant in patients with idiopathic pulmonary fibrosis in the IPF-PRO Registry Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries Year: 2018 The impact of immediate postoperative pulmonary vascular resistance on survival in patients with chronic thromboembolic pulmonary hypertension Source: Annual Congress 2009 - Pulmonary embolism Year: 2009 Exacerbations, hospitalisations and mortality in patients with idiopathic pulmonary fibrosis in clinical practice: INSIGHTS-IPF registry Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): clinical problems Year: 2017